Omeros Corporation
-
Ticker
OMER
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 51-200 Employees
- Based in Seattle, Washington
Omeros Corporation, a biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. It markets Omidria for use during cataract surgery or intraocular lens, or replacement surgery.
Omeros Corporation
Most Recent Annual Report
MOST RECENT
2020 Annual Report and Form 10K
Older/Archived Annual Reports